Anthony A. DiTonno's Insider Trades & SAST Disclosures

Anthony A. DiTonno's most recent trade in Tenax Therapeutics Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 6, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Tenax Therapeutics Inc
Anthony A. DiTonno Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 50,000 50,000 - - Stock Option (right to buy)
Tenax Therapeutics Inc
Anthony A. DiTonno Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 90,000 90,000 - - Stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades